NG2-glia are highly proliferative oligodendrocyte precursor cells (OPCs) that are widely distributed throughout the central nervous system (CNS). During development, NG2-glia predominantly differentiate into oligodendrocytes (OLs) to myelinate axon fibers, but they can also remain as OPCs persisting into the mature CNS. Interestingly, NG2-glia in the gray matter (GM) are intrinsically different from those in the white matter (WM) in terms of proliferation, differentiation, gene expression, and electrophysiological properties. Here we investigate the role of the transcriptional regulator, ASCL1, in controlling NG2-glia distribution and development in the GM and WM. In the spinal cord, ASCL1 levels are higher in WM NG2-glia than those in the GM. This differential level of ASCL1 in WM and GM NG2-glia is maintained into adult stages. Long-term clonal lineage analysis reveals that the progeny of single ASCL11 oligodendrocyte progenitors (OLPs) and NG2-glia are primarily restricted to the GM or WM, even though they undergo extensive proliferation to give rise to large clusters of OLs in the postnatal spinal cord. Conditional deletion of Ascl1 specifically in NG2-glia in the embryonic or adult spinal cord resulted in a significant reduction in the proliferation but not differentiation of these cells. These findings illustrate that ASCL1 is an intrinsic regulator of the proliferative property of NG2-glia in the CNS.
.
Indeed, local induction of NG2-glia proliferation and differentiation by neuronal activity to re-myelinate projection neurons has been shown to be a critical step for the learning of complex motor skills and behaviors in mice (Gibson et al., 2014; McKenzie et al., 2014; Xiao et al., 2016) . Thus, NG2-glia not only serve as a source to supply the necessary OLs to maintain the function and metabolic needs of neurons but also to stabilize the plasticity and dynamics of neuronal circuits.
Initially, NG2-glia was presumed to be a homogenous cell population throughout the various regions of the CNS, mostly because of a shared expression profiles of OL-lineage markers such as OLIG1/2, SOX10, and PDGFRa (Lu et al., 2002; Nishiyama et al., 2009; Stolt, Lommes, Friedrich, & Wegner, 2004; Zhou & Anderson, 2002) . However, with the advent of transgenic mice, extensive characterization of NG2-glia in vivo revealed that they are far more heterogeneous than previously appreciated. For instance, electrophysiological recordings of labeled NG2-glia in the cortical GM demonstrate that they exhibit distinct membrane potentials and expression profiles of potassium (K1) and sodium (Na1) channels than their respective counterparts in the subcortical WM or corpus callosum (Chittajallu, Aguirre, & Gallo, 2004) .
Similarly, GM NG2-glia in the brain and spinal cord, whether during neonatal development or at adult stages, are generally less proliferative, differentiate at a slower pace, and respond differently to plateletderived-growth-factor (PDGF) in comparison to WM NG2-glia (Dimou, Simon, Kirchhoff, Takebayashi, & Gotz, 2008; Hill, Patel, Medved, Reiss, & Nishiyama, 2013; Kang et al., 2010; Kang et al., 2013; Psachoulia, Jamen, Young, & Richardson, 2009; Rivers et al., 2008; Zhu et al., 2011) . Transplantation experiments suggest that GM and WM NG2-glia are intrinsically unique (Vigano, Mobius, Gotz, & Dimou, 2013) , which may be directly related to their function within these regions in the CNS. However, at present it is unclear how the intrinsic properties of NG2-glia in the GM or WM are regulated, or whether NG2-glia in the GM are derived from the same or a separate OLP lineage than those in the WM.
Previously, we and others reported that the bHLH transcription factor ASCL1, which is well known for its roles during neurogenesis, is broadly expressed in glial progenitor cells throughout the ventricular zone (VZ) at the onset of gliogenesis in the spinal cord and in the cortex (Nakatani et al., 2013; Parras et al., 2007; Sugimori et al., 2007; Sugimori et al., 2008; Vue, Kim, Parras, Guillemot, & Johnson, 2014) .
Notably, ASCL1 expression is maintained in NG2-glia as they migrate out of the ventricular zone to populate the surrounding GM and WM, but is downregulated once NG2-glia differentiate to become mature OLs (Nakatani et al., 2013; Vue et al., 2014) . Accordingly, Ascl1 mutant and conditional-knock out mice exhibit a significant decrease in the number of NG2-glia and OLs that are generated, particularly in the WM of the spinal cord (Battiste et al., 2007; Nakatani et al., 2013; Parras et al., 2007; Sugimori et al., 2007; Sugimori et al., 2008; Vue et al., 2014) , suggesting that ASCL1 may play an important role in regulating the generation of NG2-glia in the CNS. However, the precise function of ASCL1 specifically in NG2-glia during embryonic development or in the adult CNS remains unclear.
In this study, we show that the level of ASCL1 is substantially higher in WM NG2-glia than in GM NG2-glia during development of the spinal cord. Furthermore, clonal analysis using Ascl1
CreERT2 knock-in mice carrying the stochastic multicolor R26R-loxP-stop-loxP-Confetti
reporters (R26R

LSL-Confetti
; Schepers et al., 2012; Snippert et al., 2010) demonstrate that progeny from single ASCL11 OLPs labeled at embryonic day 14.5 (E14.5) are spatially restricted to the GM or WM, even though they proliferate extensively to form large clusters of SOX101;
Confetti1 OLs in the adult spinal cord. This suggests that OLPs are restricted in fate to the GM or WM by the time they express ASCL1.
Finally, conditional deletion of Ascl1 specifically in labeled (tdTomato1 or Confetti1) NG2-glia using Ng2-CreER TM mice at E14.5 or adult postnatal day (P) 30 resulted in a significant decrease in the proliferation, but not differentiation, of NG2-glia. Taken together, these findings illustrate that the level of ASCL1 plays an important role in ensuring the proper generation of the number of NG2-glia in the GM and WM of the spinal cord.
| M A T E R I A L S A N D M E T H O D S
| Mouse strains
Generation and genotyping of mouse strains were performed as previ- 
| Tamoxifen and BrdU administration
The appearance of a vaginal plug was considered E0.5 and the day of birth was noted as P0. Statistical analyses were performed as previously described (Vue et al., 2014) to assess the differences in NG2-glia cell density or per- are also Ki671 (arrowheads in middle panels, Figure 1h ,s). In contrast, none of the ASCL11 cells are positive for CC1 (arrows in bottom panels, Figure 1h ), a marker of immature and mature OLs. Thus, ASCL1 expression in the GM and WM in the spinal cord is limited specifically to OPCs/NG2-glia and not differentiated OLs.
Interestingly, a fundamental difference that we observe at this neonatal stage is that ASCL1 is expressed at a higher level in OLIG21 NG2-glia in the WM compared wit those in the GM (top panel, Figure   1h ). Indeed, by quantifying the immunofluorescent intensity of ASCL1, we found that the level of ASCL1 is twice as high in WM NG2-glia than in GM NG2-glia at P2 (Figure 1r ). To deterhmine if ASCL1 is also differentially expressed in NG2-glia in the GM and WM of the adult spinal cord, we performed immunofluorescence for ASCL1 at P30 (Figure 1i ,j). We were able to detect ASCL1 expression in OLIG21 cells in the WM (Figure 1j ), whereas ASCL1 expression in the GM was just barely detectable in some OLIG21 cells (Figure 1i ). Quantification shows that the immunofluorescence level of ASCL1 at P30 is still twice as high in the WM compared with the GM, but overall it had decreased to about half of P2 in both the GM and WM (Figure 1r ). This indicates that ASCL1 expression in NG2-glia is not only spatially but also temporally dynamic.
To confirm if ASCL1 expression in the mature spinal cord is spe- Collectively, these findings demonstrate that ASCL1 is present in OLPs in the ventricular zone at the onset of oligodendrogenesis, is differentially maintained in NG2-glia in the GM and WM, and is downregulated as development proceeds from neonatal to adult stages. ;R26R LSL-Confetti/1 spinal cords ( Figure 2d ). In particular, we identified a total of 29 ASCL1-derived SOX101;Confetti1 clones, 21
of which were found in the WM and 8 were found in the GM ( Figure   2e ). A few (5%-10%) SOX101;Confetti1 clones are situated at the GM/WM boundary, and contained cells distributed into both the GM and the WM; however, the distribution of these clones were typically uneven and still show strong bias in one area over the other (i.e., OL-1 YFP1 clone, 80% WM, 20% GM, Figure 2b ,d).
In agreement with previous reports that WM NG2-glia are more proliferative than those in the GM (Dimou et al., 2008; Young et al., 2013) , 3.3 | ASCL1 is efficiently knocked out in NG2-glia in the spinal cord ASCL1 is required for maintaining the neural progenitor pool during development as well as in areas of adult neurogenesis such as the subventricular zone (SVZ) of the lateral ventricle and the subgranular zone (SGZ) of the hippocampal dentate gyrus (Andersen et al., 2014; Kim et al., 2011) . Therefore, it is not surprising that ASCL1 is expressed in NG2-glia in both the developing and adult CNS. However, the precise requirement of ASCL1 specifically in NG2-glia at these different stages remains unclear. To address this, we used Ng2-CreER TM to conditionally delete Ascl1 Floxed alleles (Pacary et al., 2011) in embryonic NG2-glia at E14.5 or in the adult at P30. These Ng2-CreER TM mice are BAC transgenics that express a tamoxifen-inducible Cre recombinase under the control of the mouse NG2 (Cspg4) promoter/enhancer (Zhu et al., 2011) .
We first examined the efficiency of Ascl1 deletion in tdTOM- ) spinal cords from mice given tamoxifen at E14.5, and analyzed at 2, 7, 28, and 56 dpi (Figure 4a-c) . Because NG2 is also expressed in pericytes, some of which are also labeled by tdTOM, the quantification of OLIG21; tdTOM1 cells (insets, Figure 4b ) ensures that only NG2-glia derived tdTOM1 cells were being counted.
In control spinal cords (top panels, Figure 4b ), at 2 dpi there were 105 6 18 and 226 6 38 OLIG21;tdTOM1 cells/mm 2 in the GM and WM, respectively. By 7 dpi, this number had increased about 2.7-fold to 283 6 27 in the GM and 3.3-fold to 751 6 119 cells in the WM.
From 7 to 28 dpi, the number of OLIG21;tdTOM1 cells/mm 2 underwent a slight increase in the GM to 359 6 47 but was decreased in the WM to 270 6 36. This decreased in the WM is likely attributed to the fact that we are quantifying from fixed 30 lm spinal cord sections, but the area of the WM is increased by more than three-fold from 7 to 28 dpi (not shown), in addition to a significant expansion in the length of the spinal cord. Consequently, this growth of the spinal cord would result in a spreading or thinning of OLIG21;tdTOM1 cells/mm 2 area in the WM. By 56 dpi, we observed that there was an overall decrease in the number of OLIG21;tdTOM1 cells/mm 2 in both the GM (275 6 30) and WM (164 6 20; green bars, Fig. 4C ) compared with at 28 dpi. Given that the growth of the spinal cord from 28 to 56 dpi is not very drastic, it is possible that this decrease may reflect a turnover of OLIG21;tdTOM1 cells.
Overall, these findings demonstrate that embryonic NG2-glia labeled as a population at E14.5 in control spinal cords proliferate dramatically up until the first postnatal week, then their rate of proliferation decreases significantly thereafter and may completely cease by about a month of age. Accordingly, when we quantified the proportion of OLIG21;tdTOM1 cells that had expressed the OL marker CC1 (CC11; tdTOM1; blue cells, Figure 4b ), we found that none of the OLIG21; tdTOM1 were CC11 at 2 dpi, whereas around 25% were CC11 at 7 dpi. Thus, the majority of OLIG21;tdTOM1 cells within the first
postnatal week are proliferating OPCs. However, by 28 dpi, nearly all (>95%) of the OLIG21;tdTOM1 cells had become CC11 (green bars, Figure 4d ), indicating a differentiation into OLs, which clearly explains the lack of increase in OLIG21;tdTOM1 cells from 28 to 56 dpi.
Within Ascl1-CKO spinal cords (bottom panels, Figure 4b ), we observed a similar initial number of OLIG21;tdTOM1 cells/mm 2 in the GM (110 6 23) and WM (266 6 69) as seen in the control at 2 dpi (blue bars, Figure 4c ). This was expected since the initial number of OLIG21;tdTOM1 cells/mm 2 should not be affected by Ascl1-CKO. By 7 dpi, the number of OLIG21;tdTOM1 cells/mm 2 in the GM (201 6 28) and WM (404 6 76) of Ascl1-CKO spinal cords increased compared with at 2 dpi (blue bars, Figure 4c ), but this increase was less than the increase seen in the control. Furthermore, the number of OLIG21;tdTOM1 cells/mm 2 in the Ascl1-CKO spinal cords remained unchanged from 28 and 56 dpi in the GM, which was unlike in the control, and was consistently lower in the WM compared with the WM of control (blue bars, Figure 4c) . Overall, the decrease in OLIG21; tdTOM1 cells/mm 2 in the Ascl1-CKO was significant in both the GM and WM at 7, 28, and 56 dpi in comparison to control spinal cords, indicating that the proliferation of embryonic NG2-glia is compromised in the absence of ASCL1. 
| Ascl1-CKO decreases the proliferation of adult NG2-glia in the spinal cord
To determine if ASCL1 is also required for regulating the development of NG2-glia in the adult CNS, we analyzed the spinal cords of Ascl1-CKO and control littermates that were administered with two doses of tamoxifen (2.5 mg/40 g body weight) over two days starting at P30
(red arrows, Figure 5a ). The number of OLIG21;tdTOM1 cells/mm 2 in both the GM and WM of thoracic spinal cord hemisections at 1, 7, 28, and 56 dpi was determined (Figure 5b ,c).
Within control spinal cords (top panels, Figure 5b ), at 1 dpi there were 74 6 11 and 39 6 6 OLIG21;tdTOM1 cells/mm 2 in GM and WM, respectively. This number then doubled to 143 6 28 in GM and 66 6 12 in WM by 7 dpi, and more than tripled to 262 6 47 in the GM and 139 6 10 in the WM by 28 dpi. By 56 dpi, the number of OLIG21; tdTOM1 cells/mm 2 was decreased to 216 6 30 in the GM and 99 6 15 in the WM, suggesting that adult NG2-glia labeled at P30 may also start to turnover between 28 and 56 dpi (green bars, Figure 5c ).
Within Ascl1-CKO spinal cords, the initial number of OLIG21; tdTOM1 cells/mm 2 in the GM (72 6 12) and WM (45 6 11) at 1 dpi was similar to control. In contrast, although the number of OLIG21; tdTOM1 cells/mm 2 increased to 135 6 21 in GM and 56 6 14 in WM by 7 dpi in Ascl1-CKO spinal cords, this number remained relatively constant at 28 dpi (119 6 30 in GM, 50 6 10 in WM) as well as at 56 dpi (136 6 22 in GM, 49 6 11 in WM; blue bars, Figure 5c ), which was unlike what was observed for the control spinal cords. This lack of increase in the number of OLIG21;tdTOM1 cells/mm 2 in the Ascl1-CKO was statistically significant at 28 and 56 dpi, and implies that the To investigate if the failure for adult NG2-glia to increase after 7 dpi in the Ascl1-CKO was indeed due to a reduction of cell proliferation, we used bromodeoxyuridine (BrdU), a thymidine analog that is incorporated into newly synthesized DNA, to specifically label replicating cells. Control and Ascl1-CKO littermate mice were administered with two pulses of tamoxifen starting at P30, and BrdU (3 mg/25 g body weight) was then injected once per day for 10 consecutive days starting at 8-17 dpi (black arrows, Figure 5a ). We observed that there was far fewer BrdU1;tdTOM1 cells in thoracic spinal cord at 17 dpi in the Ascl1-CKO compared with controls. Indeed, by analyzing the proportion of BrdU1;tdTOM1/total OLIG21;tdTOM1 cells, we found that the percentage of proliferating cells in the control was around 18.5% in the GM and 28.1% in the WM (green bars, Figure 5e ), and was significantly reduced in the Ascl1-CKO spinal cords to 11.4% in the GM and 14.4% in the WM (blue bars, Figure 5e ). This finding strongly suggests that the decrease in the overall number of OLIG21; tdTOM1/mm 2 cells in Ascl1-CKO spinal cords is likely due to a decrease in the ability of adult NG2-glia to proliferate in the absence of ASCL1.
As in embryonic spinal cord development, we did not observe any significant difference in the percentage of CC11;tdTOM1 cells between the control and Ascl1-CKO spinal cords at 1, 7, 28, or 56 dpi following tamoxifen administration at P30 (Figure 5d ). Furthermore, both MAG and CNP were also expressed in OLIG21;tdTOM1 cells of glia to differentiate was not affected by the loss of ASCL1. However, a notable difference between OLIG21;tdTOM1 cells that were labeled by Ng2-CreER TM at P30 from those labeled at E14.5 is that around 30% of the cells were already CC11 at 1 dpi (Figure 5b ,c), compared with 0% at E14.5. Furthermore, whereas more than 95% of OLIG21; tdTOM1 cells labeled at E14.5 had differentiated to become CC11 by 28 dpi (Figure 4d ), only about 70% of OLIG21;tdTOM1 cells labeled at P30 were CC11, even at 56 dpi (Figure 5d ). This indicates that adult NG2-glia proliferate and differentiate at a much slower pace than embryonic NG2-glia in the spinal cord, and about 30% of the adult NG2-glia, as labeled by Ng2-CreER TM , may continue to remain undifferentiated on a long-term basis.
3.6 | The size of NG2-glia clones is decreased in the absence of ASCL1 labeled by tdTOM, was also decreased with Ascl1-CKO (Figure 4b,c) .
A notable feature that we frequently observed was that Ascl1-CKO ;R26R LSL-Confetti spinal cords, which comprised a total of about 800 labeled cells that were similarly distributed into the GM and WM. About 45% of these clones were single cell clones, 50%
were clones that contained between 2 and 9 cells, while the remaining 5% were larger clones containing between 10 and 15 cells (green bars, Figure 7f ,g). Quantification revealed that the average number of cells per clone for these P30 control NG2-glia clones was 3.0 6 0.2 in the GM and 2.8 6 0.2 in the WM (green bars, Figure 7h ), which was noticeably lower than the embryonic NG2 clones labeled at E14.5
(green bars, Figure 7d ).
In contrast, we identified only about 180 Ascl1-CKO Confetti1 clones in both the GM and WM of Ng2-CreER nearly half (1.7 6 0.1 in the GM and 1.6 6 0.1 in the WM) compared with control clones (green bars, Figure 7h ).
Collectively, these findings demonstrate that at the clonal level, the proliferation of NG2-glia is highly dynamic, and on average is reduced by two to three-fold as development proceeds from the embryo into the adult. Furthermore, ASCL1 seems to play a vital role in shaping the survival as well as the proliferation of NG2-glia, as the number of Confetti-labeled NG2-glia clones is reduced with Ascl1-CKO and the size of NG2-glia clones seems to favor the generation of smaller clones at the expense of larger highly proliferative NG2-glia clones.
| Complete deletion of Ascl1 with Olig1
Cre decreases the number but not differentiation of OLIG21 cells in the spinal cord ;Control (a-g) or Olig1
Cre/1
;Ascl1-CKO (h-n) spinal cords at P0 or P14. ASCL1 is no longer expressed in NG2-glia in the GM and WM of Ascl1-CKO (i and j) as in control (b and c). Number of OLIG21 cells is noticeably decreased in WM of Ascl1-CKO at P0 and P14, but expression of PDGFRa (k), MBP (m) and CC1 (n) are unaffected and similar to control (d, f, and g). NEUN marks GM and dotted lines in F and L indicated GM/WM boundary. Scale bar is 100 lm for a, e, f, h, l, and m; and 25 lm for b, c, d, g, i, j, k, and n. (o) The Olig1
Cre/6 ;Ascl1-CKO mice were able to survive postnatally and continued to exhibit a decrease of OLIG21 cells in the WM at P14 (Figure 8l) . Quantification of the number of OLIG21 cells/mm 2 in the GM revealed that it was similar between control (622 6 35) and Ascl1-CKO (594 6 64) at P0 but was slightly decreased in the Ascl1-CKO at P14 (797 6 43 Ascl1-CKO vs. 883 6 42 control), though this decreased was not significant (blue vs. green bars, Figure 8o ). In the WM, the number of OLIG21 cells/mm 2 was decreased by about 40%
in the Ascl1-CKO compared with control at both P0 and P14 (blue vs.
green bars, Figure 8o ). This decreased in OLIG21 cells in the WM but not GM was similar to our previous study in which Ascl1 was conditionally knocked out in OLPs at E14.5 using Ascl1 CreERT2 (Nakatani et al., 2013; Vue et al., 2014) .
To determine if the differentiation of NG2-glia was affected by the complete loss of ASCL1, we next performed immunofluorescence for OL-differentiation markers for spinal cords at P14. We found that both CC1 and MBP are still expressed in the GM and WM of Ascl1- 
| DISCUSSION
The generation, development, and differentiation of NG2-glia in the CNS is a complex process across both space and time, and requires the precise regulation and function of multiple genes, particularly those encoding transcription factors (Olig1/2, Nkx2.2, Ascl1, Sox10, Prox1, Smarca4/Brg1, Myrf, and Sox17; Hornig et al., 2013; Kato et al., 2015; Li, Lu, Smith, & Richardson, 2007; Lu et al., 2002; Stolt et al., 2004; Sugimori et al., 2007; Sugimori et al., 2008; Yu et al., 2013; Zhou, Choi, & Anderson, 2001; Zhou & Anderson, 2002; Zhu et al., 2014) . We observed that one of the first fundamental differences between GM and WM NG2-glia in the spinal cord is the level of ASCL1 expression. Indeed, by quantifying the immunofluorescence of ASCL1 specifically in OLIG21;PDGFR1 NG2-glia, we found that it is twice as high in WM NG2-glia than in GM NG2-glia (Figure 1g ,r). This difference was apparent from embryonic development up until a month of age, was specific to ASCL1 but not OLIG2 (not shown), and is suggestive that the high and low levels of ASCL1 is a direct reflection of the diversification and heterogeneity of NG2-lineage cells in the WM and GM, respectively ( Figure 9a ). Several lines of evidence support this interpretation. First, in loss of function studies, Ascl1-mutant mice, though neonatal lethal, exhibit a dramatic decrease in the number of OLIG21 cells that are generated in the WM Sugimori et al., 2008) . Similarly, conditional knock-out of Ascl1 in glial progenitors in the embryonic spinal cord or neonatal brain resulted in a significant and persistent reduction in the number of OL-lineage (OLIG21 and SOX101) cells that are generated in the WM (Figure 8 ; Nakatani et al., 2013; Vue et al., 2014) . In some of these instances, generation of OLIG21 cells in GM was not as adversely affected, which might be expected since WM NG2-glia express a higher level of ASCL1 and therefore may be more dependent on ASCL1 for generation than GM NG2-glia.
The second line of evidence comes from studies which demonstrate that there are intrinsic differences between NG2-glia in the GM and WM in terms of gene expression, electrophysiological properties, proliferation and differentiation rates, and response to PDGF or the surrounding environment (Chittajallu et al., 2004; Dimou et al., 2008; Hill et al., 2013; Kang et al., 2010; Psachoulia et al., 2009; Vigano et al., 2013) . Whether these differences are directly determined by or attributable to the differential level of ASCL1 remains to be tested. Nevertheless, they are an indication that GM and WM NG2-glia are distinct and may be derived from separate OLP populations. In agreement with this, our clonal analysis of the spinal cords of Ascl1 , 2007; Sugimori et al., 2008) , and in the first few weeks following conditional deletion of Ascl1 in OLPs embryonically (Vue et al., 2014) . We extend these findings and provide insight into the long-term effect of Ascl1 deletion specifically in NG2-glia during embryonic and adult spinal cord oligodendrogenesis. We observed a significant, persistent reduction in the number of NG2-glia derived tdTOM1 cells in the GM and WM of the spinal cord following conditional deletion of Ascl1 at E14.5 or P30 (Figures 4c and 5c ). The reduction of BrdU incorporation in the tdTOM1 cells indicates that this decrease in cell number is due to decreased proliferation, although it is possible that an increase in cell death may also occur for NG2-glia in the absence of ASCL1. This interpretation was supported by long-term clonal lineage analysis of NG2-glia clones, which on average contain not only more cells per clone but also more clones overall in the presence rather than the absence of ASCL1 (Figure 7 ).
Interestingly, in contrast to the observed effect on the number of OLIG21;tdTOM1 NG2-glia in the embryonic and adult spinal cord following Ascl1 deletion, the proportion of these labeled NG2-glia in the GM or WM that had differentiated into mature CC11 OLs was not significantly altered at any time point analyzed (Figures 4 and 5) . These results are in stark contrast with a prior report showing a drastic reduction in the number of myelin-expressing OLs in the WM of the spinal cords of Ascl1-mutant mice at P0, a finding that was attributed to impaired or delayed differentiation of Ascl1-mutant NG2-glia Sugimori et al., 2008) . These contrasting findings suggest that while ASCL1 may be required to ensure proper generation and differentiation of NG2-glia, the direct long-term consequences of ASCL1 loss are on proliferation, and potentially survival, but not differentiation of NG2-glia in both the embryonic and adult spinal cord (Figure 9b ).
This finding is not surprising considering that key factors such as NKX2.2, OLIG1/2 and SOX10, which have been shown to be crucial for NG2-glia differentiation, are still present and are not affected by the loss of ASCL1. In contrast, Olig1
Cre conditional knock-out of Pdgfra resulted in a drastic decrease in the number of OPC/NG2-glia in the spinal cord (Zhu et al., 2014) , a phenotype that is similar but more severe than the Olig1
Cre ;Ascl1-CKO observed in this study (Figure 8 ).
Because PDGFRa expression is unaffected by ASCL1 loss (Figure 8k ), this suggests a possible mechanism by which ASCL1 functions in parallel or downstream of PDGFRa to regulate NG2-glia proliferation.
| Potential mechanism and targets of ASCL1 function in NG2-glia
A fundamental question that needs to be addressed is how ASCL1 differentially regulates NG2-glia proliferation in the GM and WM. Our finding that higher level of ASCL1 is correlated with a higher proliferation rate of NG2-glia in the WM over the GM, and in embryonic and neonatal stages over adult stages implies that the level of ASCL1 is critical for controlling the differential proliferation of NG2 glia. This implication of different levels of ASCL1 controlling its function within progenitor cells has been previously described. For instance, time-lapse imaging of brain slices or neural progenitors in culture revealed that the level of ASCL1, along with OLIG2 and HES1, when fused with reporter proteins oscillates within the cells. Moreover, sustained high levels of ASCL1 promotes cell fate specification and differentiation, whereas lower levels of ASCL1 oscillation promotes cell division (Imayoshi et al., 2013) . In agreement with this, ASCL1 expression in neural progenitors in the ventricular zone, whether during neurogenesis or gliogenesis (Figure 1a-e), is relatively high, and may allow ASCL1 to function to ensure proper specification and differentiation of interneurons and OPCs/ NG2-glia (Helms et al., 2005; Parras et al., 2004; Parras et al., 2007; Sugimori et al., 2007) . In contrast, the overall level of ASCL1 in NG2-glia in the GM and WM, though can be readily detected in neonatal, and to some extent, adult stages (Figure 1f -j,r), is much lower and may only be at levels sufficient to promote cell division but not differentiation. This would explain how a higher level of ASCL1 in WM NG2-glia would promote these cells to proliferate at a faster rate than GM NG2-glia (Figure 2) , and the lack of ASCL1's role in NG2-glia differentiation.
ASCL1, like other bHLH proteins, functions by forming heterodimers with ubiquitously expressed E-protein (E47) to bind to DNA to regulate gene expression (Castro et al., 2006) . Currently, it is unknown whether ASCL1 dimerizes with E47 or different dimerization partners to differentially regulate the proliferation of NG2-glia in the GM and WM.
However, since ASCL1 shows strong preferences in binding to canonical E-box (CANNTG) motifs in the genome of highly proliferative neural progenitors and cancer cells (Castro et al., 2006; Borromeo et al., 2014; Borromeo et al., 2016) , it is likely that E47 may also be a dimerization partner in NG2-glia. Recently, a critical role for ASCL1 in regulating neural progenitor cell proliferation has been reported. In particular, Castro et al. (2011) showed that although ASCL1 directly regulates genes critical for the specification and terminal differentiation of neural progenitors in the embryonic ventral telencephalon, a number of direct transcriptional targets also include positive cell cycle genes and oncogenic transcription factors such as E2f1, FoxM1, Cdca7, Tead1/2, and Taz. More recently, Garcez et al. (2015) also demonstrated that ASCL1 directly regulates Cenpj/CPAP, a gene that is critical for centrosome formation and normal mitosis in neural progenitors. Given ASCL1's specific role in regulating NG2-glia proliferation, it is possible that some of these genes may also be directly or differentially regulated by ASCL1 in NG2-glia in the GM and WM of the spinal cord, and in other regions of the CNS.
| C O NC LU S I O N S
Taken together, our lineage tracing analysis at both the population and clonal level provides new insight into the developmental dynamics of NG2-glia, enabling comparison of long-term NG2-glia development in the embryonic versus adult spinal cord and in the GM versus WM.
More importantly, our findings suggest that ASCL1 is a critical regulator of the proliferative capacity of GM and WM NG2-glia in both the embryonic and adult spinal cord. These results highlight a role for ASCL1 in balancing OPC/NG2-glia proliferation and maintenance with myelin remodeling in the spinal cord throughout adult life. Indeed, it is possible that ASCL1's expression may underlie the local induction of NG2-glia proliferation and differentiation by neuronal activity that gives rises to OLs capable of re-myelinating projection neurons, a step that was recently shown to be critical for the learning of complex motors tasks in mice (Gibson et al., 2014; McKenzie et al., 2014; Xiao et al., 2016) . Lastly, prior studies have suggested that NG2-glia represent a potential cell of origin for some gliomas, such as glioblastoma multiforme, an aggressive, treatment-resistant brain tumor characterized by high ASCL1 expression (Lei et al., 2011; Liu et al., 2011 ). An understanding of ASCL1's role in regulating the proliferation of NG2-glia may therefore provide new insights into the formation and progression of these cancers.
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